Shanghai Lymphoma Clinical Cohort

Sponsor
Ruijin Hospital
Study ID
NCT07285174
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No interventions need to be specified for this study — OTHER
    No interventions need to be specified for this study

Study Details

The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.

Key Dates

First listed
Dec 16, 2025
Start date
Dec 18, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2029

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Shanghai Lymphoma Clinical Cohort
    Shanghai Lymphoma Clinical Cohort

Primary Outcome Measure

Progression Free Survival (PFS) [ Time Frame: Baseline up to data cut-off (up to approximately 1 year) ]

Central Contacts

Related Studies